Drug class in one race
CD123 drugs for Acute Myeloid Leukemia
7 tracked CD123 drugs in the Acute Myeloid Leukemia race. The class explanation lives on the CD123 page; the full indication pipeline across every mechanism is on the Acute Myeloid Leukemia page.
1 Phase 2/31 Phase 22 Phase 1/23 Phase 1
Head-to-head evidence: Allo-RevCAR01-T vs CD123 targeted CAR-NK cells · Allo-RevCAR01-T vs SAR443579 · Allo-RevCAR01-T vs Tagraxofusp · Anti-CD123 CAR NK cells vs CD123 targeted CAR-NK cells · Anti-CD123 CAR NK cells vs SAR443579 · Anti-CD123 CAR NK cells vs Tagraxofusp